Abstract
EXTRAORDINARY INTRUSION is the way mass urine screening of employees for drugs of abuse is regarded by John P. Morgan, MD, director of pharmacology, Mount Sinai School of Medicine, City University of New York. Inappropriate, tarted-up numbers are being cited as if they were scientific data to support policy, he charged. Morgan spoke at the first scientific consensus conference on Pharmacologic Implications of Urine Screening for Illicit Substances of Abuse, held recently in San Diego in conjunction with the annual meeting of the American Society for Clinical Pharmacology and Therapeutics (ASCPT). He represents one side of a controversy that is no closer to being resolved today than it was before the experts assembled to conduct a scientific review of the evidence. The other side is represented with statements such as, Drug testing prevents drug abuse when it is part of a company's whole drug-control program. That is the opinion
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
